Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A prostate cancer detection software system to help pathologists quickly identify suspicious areas of tissue, developed by Paige, will be investigated in a multicentre clinical study led by Oxford University as part of a successful NHSx Artificial Intelligence Health and Care Award application.

" "

Paige Prostate automatically detects and highlights areas of suspicious tissue, allowing the pathologist to quickly identify if cancer is present in the patient biopsy. The software also measures and grades the severity of tumours it detects, all of which assists the pathologist in accurately and efficiently diagnosing cancer and influencing important treatment decisions in patients with prostate cancer.

This award means that Oxford University and its NHS partners North Bristol NHS Trust and University Hospitals Coventry and Warwickshire, together with Oxford University Hospitals NHS Foundation Trust, will use Paige Prostate prospectively in a real-world cancer laboratory setting, taking the technology one step closer to widespread use in the NHS to benefit patients.

Oxford University was one of five lead organisations to receive Phase 4 funding, which was announced by the Health and Social Care Secretary Matt Hancock on 16 June 2021. The AI Award is a significant government initiative making £140 million available over four years to accelerate the testing and evaluation of artificial intelligence technologies which meet the aims set out in the NHS Long Term Plan.

Associate Professor Clare Verrill from Oxford University’s Nuffield Department of Surgical Sciences and Oxford University Hospitals NHS Foundation Trust is a leading pathologist and Principal Investigator on the study and Dr Margaret Horton, Business Lead for Europe at Paige is a co-Investigator. 'I see this both as a natural evolution and key transformational point for histopathology. With this award we can advance the adoption of powerful technology to help pathologists by demonstrating the system-wide potential of using AI-based diagnostic systems in routine reporting' said Professor Verrill. 

'The NHSx program provides the ideal catalyst for the system-wide adoption of artificial intelligence-based technologies such as Paige Prostate to improve efficiency, accuracy and patient and staff experiences. The pathologists and principal investigators in this study are global leaders in the implementation of digital pathology and utilising innovation to advance diagnostic service delivery' continued Dr Horton. 

Dr Leo Grady, Chief Executive Officer of Paige, commented: 'Computational pathology for diagnostics has clear potential to increase diagnostic accuracy and more efficiently utilise scarce diagnostic resources in the NHS and in other health systems around the world. The next clear step to bring this to routine practice is pathologist-led implementation in every day practice to demonstrate and measure benefits to patients, laboratories and the NHS. This exciting work with Oxford University and their NHS partners is a tremendous achievement and Paige is very proud to be working with them in transforming the important work that pathologists do.'

The AI Award is one of the programmes that make up the NHS AI Lab, led by NHSX and delivered in partnership with the Accelerated Access Collaborative (AAC) and National Institute for Health Research (NIHR).

Dan Bamford, Deputy Director AI Award, Accelerated Access Collaborative, said: ‘Congratulations to Oxford University and its NHS partners on their success as one of our winners of the AI Award. We look forward to working with them as they develop and test the Paige Prostate technology further, so that more patients can benefit from this cutting-edge artificial intelligence.’

Dr Indra Joshi, Director of AI, NHSX, said: ‘With this latest round of AI Award winners, we now have an incredible breadth of expertise across a wide range of clinical and operational areas. Through this award, Oxford University and its NHS partners will be at the forefront of applying artificial intelligence in new ways to transform health and care.’

This is a histopathologist led study and builds on investments made in digital pathology technology and infrastructure as part of the PathLAKE Centre of Excellence for digital pathology and artificial intelligence. Professor Verrill’s experimental pathology work is supported by the NIHR Oxford Biomedical Research Centre.

Media coverage

Oxford University and partners win government funding to evaluate Paige Prostate Cancer Detection System
Business Leader, 18/06/2021

Similar stories

Clare Verrill receives Turing Fellowship

Thirty-three University of Oxford researchers have been named Turing Fellows for the 2021/22 academic year, including Associate Professor Clare Verrill from the Nuffield Department of Surgical Sciences (NDS).

Researchers awarded Wellcome Innovator Grant to investigate role of brainstem nucleus in human consciousness

Researchers at Oxford University have received a prestigious Wellcome Innovator Grant for investigating the role of the pedunculopontine nucleus (PPN) – a brainstem nucleus – in human consciousness.

Jonathan Meakins to be inducted into Canadian Medical Hall of Fame

Professor Jonathan L. Meakins, who was Head of the Nuffield Department of Surgery from 2002 to 2008, has been selected for induction into the Canadian Medical Hall of Fame.

NDS Staff Awards presented at garden party

A number of staff from the Nuffield Department of Surgical Sciences (NDS) have been honoured at an annual awards ceremony.

New Associate Professors announced

The University of Oxford has announced the promotion to Associate Professor of two senior academics at the Nuffield Department of Surgical Sciences.

Regent Lee wins top UKRI Future Leaders Fellowship

Dr Regent Lee of the Nuffield Department of Surgical Sciences is one of eight Oxford University academics who have been awarded significant financial funding from the UK Research and Innovation’s (UKRI) Future Leaders Fellowships Scheme.

Blog posts

My virtual work experience with NDS and NDORMS

Louise Tan, a Year 12 student from Ballyclare in County Antrim, Northern Ireland, recently attended the joint NDS and NDORMS Virtual Work Experience. In this guest blog, Louise reflects on her experience.

Celebrating women of NDS

To celebrate 100 years since women were admitted as full members of the University and on the occasion of International Women's Day, a group of inspirational women in the Nuffield Department of Surgical Sciences (NDS) reflect on their journeys, their place in Medical Sciences and their vision for the next 100 years.

The life of a research nurse: supporting the Oxford COVID-19 Vaccine Trial

Research nurses in the NHS are playing a crucial role in helping to trial new coronavirus treatments and vaccines. Three NDS research nurses stepped up to help with the fight against this new disease. Here Bhumika Patel shares her experience of working on the Oxford COVID-19 Vaccine Trial.

Why I became a Peer Supporter

The Peer Support Programme was developed in recognition of the essential role students play in supporting and encouraging one another on a day-to-day basis throughout their time at university. NDS’ own Helen Stark discusses her experience of becoming a Peer Supporter.

Racism under the microscope

As Black History Month gets underway in the UK, NDS Athena SWAN Coordinator Emily Hotine puts racism under the microscope.